Showing results (131-140 of 454) with videos related to

Sort By:
Pageof 46
Therapeutics and Clinical Risk Management|April 4, 2023
Economic Evaluation for Palbociclib Plus Fulvestrant vs Ribociclib Plus Fulvestrant and Abemaciclib Plus Fulvestrant in Endocrine-Resistant Advanced or Metastatic Breast Cancer in ItalyGiorgio Lorenzo Colombo, Maria Chiara Valentino, Alessandra Fabi, et al.
Cancers|March 29, 2023
Overview of Trop-2 in Cancer: From Pre-Clinical Studies to Future Directions in Clinical SettingsPasquale Lombardi, Marco Filetti, Rosa Falcone, et al.
Future Oncology (London, England)|July 23, 2025
Management of trastuzumab deruxtecan-related adverse events in breast cancer: Italian expert panel recommendationsGiampaolo Bianchini, Alessandra Fabi, Valentina Guarneri, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 24, 2013
An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza studyCarlo Lazzaro, Roberto Bordonaro, Francesco Cognetti, et al.
Anticancer Research|May 25, 2004
Alfa-epoietin and anaemia in gynaecological cancerBarbara Di Cocco, Nello Salesi, Alessandra Fabi, et al.
Anticancer Research|August 17, 2005
Nail disorders in a woman treated with ixabepilone for metastatic breast cancerAndrea Alimonti, Chiara Nardoni, Paola Papaldo, et al.
Cancers|September 9, 2022
Updated Neoadjuvant Treatment Landscape for Early Triple Negative Breast Cancer: Immunotherapy, Potential Predictive Biomarkers, and Novel AgentsGiovanna Garufi, Luisa Carbognin, Francesco Schettini, et al.
Biosensors|October 27, 2022
An Origami Paper-Based Biosensor for Allergen Detection by Chemiluminescence Immunoassay on Magnetic MicrobeadsElisa Lazzarini, Andrea Pace, Ilaria Trozzi, et al.
Journal of Neurosurgery|February 13, 2002
Quality-of-life assessment in patients who had been surgically treated for cerebellar pilocytic astrocytoma in childhoodAlfredo Pompili, Marco Caperle, Andrea Pace, et al.
Cancer Treatment Reviews|June 13, 2006
Early switch with aromatase inhibitors as adjuvant hormonal therapy for postmenopausal breast cancer: pooled-analysis of 8794 patientsEmilio Bria, Mariangela Ciccarese, Diana Giannarelli, et al.
Pageof 46